# EDGAR Filing Document

**Accession Number:** 0001916558
**File Stem:** 0001079973-26-000654
**Filing Date:** 2026-5
**Character Count:** 65701
**Document Hash:** 183030c25ef0ebacce23a38b30f4ccb7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001079973-26-000654.hdr.sgml**: 20260514

**ACCESSION NUMBER**: 0001079973-26-000654

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 44

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260514

**DATE AS OF CHANGE**: 20260514

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tradewinds Universal
- **CENTRAL INDEX KEY:** 0001916558
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 844254479
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56700
- **FILM NUMBER:** 26976264

**BUSINESS ADDRESS:**
- **STREET 1:** 501 MERCURY LANE
- **CITY:** BREA
- **STATE:** CA
- **ZIP:** 92821
- **BUSINESS PHONE:** 855-434-4488

**MAIL ADDRESS:**
- **STREET 1:** 501 MERCURY LANE
- **CITY:** BREA
- **STATE:** CA
- **ZIP:** 92821

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Tradewinds Enterprises, Inc.
- **DATE OF NAME CHANGE:** 20220310

?xml version='1.0' encoding='ASCII'?

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**Form 10-Q**

☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

**For the quarter ended March 31, 2026**

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Commission file number: 333-276233

**Tradewinds Universal**

*(Exact name of registrant as specified in its charter)*

———————

---

| | | |
|:---|:---|:---|
| **Wyoming** | **2000** | **87-4254479** |
| (State or other jurisdiction of<br> incorporation or organization) | (Primary Standard Industrial<br> Classification Code Number) | (I.R.S. Employer Identification<br> Code Number) |

---

**501 Mercury Lane Brea, CA. 92821 855-434-4488 TradewindsUniversal.com Andrewreadtw@gmail.com**

(Address and telephone number of registrant's principal executive offices and principal place of business)

**Buffalo Registered Agents LLC 401 N Main Street Buffalo, WY 82834 855-434-4488**

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated Filer | ☐ | Accelerated Filer | ☐ |
| Non-accelerated Filer | ☒ | Smaller reporting company | ☒ |
| (Do not check if a smaller reporting company) | (Do not check if a smaller reporting company) | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Number of shares of registrant's common stock, par value $.001, outstanding as of May 14, 2026: 43,690,580.

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | &nbsp;&nbsp;**PAGE** |
| &nbsp;&nbsp;**Part I** |  |  |
| &nbsp;&nbsp;**ITEM 1** | Financial Statements | &nbsp;&nbsp;4 |
| &nbsp;&nbsp;**ITEM 2** | Management's Discussion and Analysis of Financial Condition and Results of Operations | &nbsp;&nbsp;15 |
| &nbsp;&nbsp;**ITEM 3** | Quantitative and Qualitative Disclosures about Market Risk | &nbsp;&nbsp;17 |
| &nbsp;&nbsp;**ITEM 4** | Controls and Procedures | &nbsp;&nbsp;17 |
| &nbsp;&nbsp;**Part II** |  |  |
| &nbsp;&nbsp;**ITEM 1** | Legal Proceedings | &nbsp;&nbsp;17 |
| &nbsp;&nbsp;**ITEM 1A** | Risk Factors | &nbsp;&nbsp;17 |
| &nbsp;&nbsp;**ITEM 2** | Unregistered Sales of Equity Securities and Use of Proceeds | &nbsp;&nbsp;18 |
| &nbsp;&nbsp;**ITEM 3** | Defaults Upon Senior Securities | &nbsp;&nbsp;18 |
| &nbsp;&nbsp;**ITEM 4** | Mine Safety Disclosures | &nbsp;&nbsp;19 |
| &nbsp;&nbsp;**ITEM 5** | Other Information | &nbsp;&nbsp;19 |
| &nbsp;&nbsp;**ITEM 6** | Exhibits | &nbsp;&nbsp;19 |
|  | Signatures | &nbsp;&nbsp;19 |

---

 **Financial Statements**

**Tradewinds Universal**

**Table of Contents**

**March 31, 2026** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;Financial Statements | &nbsp;&nbsp;4 |
| &nbsp;&nbsp;Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025 (audited) | &nbsp;&nbsp;4 |
| &nbsp;&nbsp;Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited) | &nbsp;&nbsp;5 |
| &nbsp;&nbsp;Statements of Stockholders' Equity for the three months ended March 31, 2026, and 2025 (unaudited) | &nbsp;&nbsp;6 |
| &nbsp;&nbsp;Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (unaudited) | &nbsp;&nbsp;7 |
| &nbsp;&nbsp;Notes to the Financial Statements March 31, 2026 (Unaudited) | &nbsp;&nbsp;8 |

---

**TRADEWINDS UNIVERSAL**

**BALANCE SHEETS AS OF MARCH 31, 2026 AND DECEMBER 31, 2025**

---

| | | |
|:---|:---|:---|
|  | **March 31,<br> 2026**<br> **(Unaudited)** | **December 31, <br> 2025** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and Cash Equivalents | $15597 | $16638 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid Expense | 12945 | 25445 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts Receivable | 48950 | 48750 |
| &nbsp;&nbsp;Total Current Assets | 77492 | 90833 |
| &nbsp;&nbsp;Other Assets-Intangible Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible Asset - AI App - net of Amortization | 180000 | 190000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Formula-Pets-net | 25000 | 25000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trademarks | 1500 | 1500 |
| &nbsp;&nbsp;Total Other Assets (net) | $206500 | $216500 |
| &nbsp;&nbsp;Total Assets | 283992 | 307333 |
| &nbsp;&nbsp;Liabilities and Stockholders' Equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts Payable | $27000 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan Payable | 25000 |  |
| &nbsp;&nbsp;Total Current Liabilities | 52000 |  |
| &nbsp;&nbsp;Total Liabilities | 52000 |  |
| &nbsp;&nbsp;Commitments and Contingencies (Note 3) |  |  |
| &nbsp;&nbsp;Stockholders' Equity |  |  |
| &nbsp;&nbsp;Common stock, $0.001 par value, 75,000,000 shares authorized, 43,690,580 issued and outstanding at March 31, 2026 and 42,690,580 issued and outstanding at December 31, 2025 | 43691 | 42691 |
| &nbsp;&nbsp;Additional Paid in Capital | 1496709 | 1447709 |
| &nbsp;&nbsp;Accumulated Deficit | (1308408) | (1183067) |
| &nbsp;&nbsp;Total Stockholders' Equity | 231992 | 307333 |
| &nbsp;&nbsp;Total Liabilities and Stockholders' Equity | $283992 | $307333 |

---

The accompanying notes are an integral part of these unaudited financial statements

**TRADEWINDS UNIVERSAL**

**STATEMENTS OF OPERATIONS** 

**FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND MARCH 31, 2025**

---

| | | |
|:---|:---|:---|
|  | **March 31,<br> 2026**<br> **(unaudited)** | **March 31,<br> 2025**<br> **(unaudited)** |
| Revenue | $21800 | $12972 |
| Gross Profit | 21800 | 12972 |
| Operating Expenses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketing | 64178 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Advertising | 411 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional Fees | 23796 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Consulting | 43700 | 12650 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization | 10000 | 1200 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and Administrative | 5056 | 234 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on Impairment |  |  |
| Total Operating Expenses | 147141 | 14084 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Loss Before Taxes | (125341) | (1112) |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for Income Tax |  |  |
| Net Loss | $(125341) | $(1112) |
| Net Loss Per Share – Basic and Diluted | $(0.00) | $(0.00) |
| Basic and diluted weighted average shares used in the calculation of net loss per common share | 43418358 | 32170000 |

---

The accompanying notes are an integral part of these unaudited financial statements.

**TRADEWINDS UNIVERSAL**

**STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY**

**FOR THE THREE MONTHS ENDED MARCH 31, 2026 (Unaudited) AND MARCH 31, 2025 (Unaudited)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Shares** | **Common Shares Amount** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Total**<br> **Stockholders' Equity** |
| &nbsp;&nbsp;Balance December 31, 2024 | 32170000 | $32170 | $289530 | $(290190) | $31510 |
| &nbsp;&nbsp;Net Loss |  |  |  | (1112) | (1112) |
| &nbsp;&nbsp;Balance March 31, 2025 | 32170000 | $32170 | $289530 | $(291302) | $30398 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Shares** | **Common Shares Amount** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Total**<br> **Stockholders' Equity** |
| &nbsp;&nbsp;Balance December 31, 2025 | 42690580 | $42691 | $1447709 | $(1183067) | 307333 |
| &nbsp;&nbsp;Shares Issued for Cash | 1000000 | 1000 | 49000 |  | 50000 |
| &nbsp;&nbsp;Net Loss |  |  |  | (125341) | (125341) |
| &nbsp;&nbsp;Balance March 31, 2026 | 43690580 | $43691 | $1496709 | $(1308408) | $231992 |

---

The accompanying notes are an integral part of these unaudited financial statements

**TRADEWINDS UNIVERSAL**

**STATEMENTS OF CASH FLOWS** 

**FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND MARCH 31, 2025**

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026**<br> **(unaudited)** | **March 31, 2025**<br> **(unaudited)** |
| &nbsp;&nbsp;Operating Activities |  |  |
| &nbsp;&nbsp; Net Loss | $(125341) | $(1112) |
| &nbsp;&nbsp;Adjustments to Reconcile Net Loss to Net Cash from Operating Activities |  |  |
| &nbsp;&nbsp; Amortization | 10000 | 1200 |
| &nbsp;&nbsp;Changes in Operating Assets and Liabilities |  |  |
| &nbsp;&nbsp; Prepaid Expense | 12500 |  |
| &nbsp;&nbsp; Accounts Payable | 27000 |  |
| &nbsp;&nbsp; Accounts Receivable | (200) |  |
| &nbsp;&nbsp; Net Cash Provided by Operating Activities | (76041) | 88 |
| &nbsp;&nbsp;Investing Activities |  |  |
| &nbsp;&nbsp;Net Cash Provided by Investing Activities |  |  |
| &nbsp;&nbsp;Financing Activities |  |  |
| &nbsp;&nbsp; Loan | 25000 |  |
| &nbsp;&nbsp; Common Stock | 50000 |  |
| &nbsp;&nbsp;Net Cash from Financing Activities | 75000 |  |
| &nbsp;&nbsp;Net Change in Cash and Cash Equivalents | (1041) | 88 |
| &nbsp;&nbsp;Cash and Cash Equivalents at Beginning of Period | 16638 | 210 |
| &nbsp;&nbsp;Cash and Cash Equivalents at End of Period | $15597 | $298 |
| &nbsp;&nbsp;Supplemental Cash Flow Information |  |  |
| &nbsp;&nbsp;Cash Paid for Interest | $— | $— |
| &nbsp;&nbsp;Cash Paid for Taxes | $— | $— |

---

The accompanying notes are an integral part of these unaudited financial statements

**TRADEWINDS UNIVERSAL**

**NOTES TO THE FINANCIAL STATEMENTS**

**March 31, 2026 (Unaudited)**

**Note 1 – Nature of Operations**

*Nature of Operations*

Tradewinds Universal, Inc. (the "Company") was incorporated in the State of Wyoming on December 28, 2021. The Company operates as a holding company focused on acquiring, developing, and managing businesses with long-term value, resilience, and growth potential.

The Company's initial operations focused on the development and distribution of high-nutrition foods and beverages, including edible insect protein-based products. In 2022, the Company acquired a canine pain relief formula for development into pet-related products. During the year ended December 31, 2025, the Company expanded its strategic focus to include distribution and licensing activities.

On August 19, 2025, we entered into a non-binding Letter of Intent, or LOI, with Scar Holdings LLC, also known as Peppermint Hippo™, regarding the potential formation of a division focused on the acquisition and development of nightlife and hospitality venues under the Peppermint Hippo brand.

The first proposed acquisition contemplated by the LOI is Peppermint Hippo Toledo, located in Toledo, Ohio. The LOI further contemplates that we may, together with Peppermint Hippo, evaluate the possible acquisition of additional Peppermint Hippo-branded venues over time.

The LOI is non-binding and no definitive acquisition agreement has been entered into with respect to Peppermint Hippo Toledo or any other venue. Completion of any acquisition would be subject to a number of conditions, including completion of due diligence, negotiation and execution of definitive agreements, receipt of required consents, financing, and regulatory and licensing approvals. As a result, there can be no assurance that we will complete the acquisition of Peppermint Hippo Toledo, pursue any additional acquisition opportunity with Peppermint Hippo, or otherwise establish a nightlife and hospitality division.

**Note 2 - Summary of Significant Accounting Policies**

*Basis of Presentation*

The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and the rules and regulations of the Securities and Exchange Commission ("SEC"). In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the Company's financial position as of March 31, 2026 and December 31, 2025 and the results of operations and cash flows for the three months ended March 31, 2026 and 2025 have been included.

*Estimates*

The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts. Accordingly, actual results could differ from those estimates.

*Cash And Cash Equivalents*

The Company maintains cash balances in non-interest-bearing accounts that currently do not exceed federally insured limits. For purposes of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered cash equivalents. There were no cash equivalents as of March 31, 2026, March 31, 2025, or December 31, 2025.

*Accounts Receivable*

Accounts receivable consist of trade receivables and are stated at the amount management expects to collect. As of March 31, 2026 and December 31, 2025, accounts receivable totaled $48,950 and $48,750, respectively.

The Company evaluates accounts receivable for expected credit losses in accordance with ASC 326, Financial Instruments—Credit Losses. In estimating expected credit losses, management considers relevant available information, including historical collection experience, the financial condition and creditworthiness of the customer, current economic conditions, and reasonable and supportable forecasts of future conditions that may affect collectibility. Based on this evaluation, no allowance for credit losses was recorded as of March 31, 2026 or December 31, 2025.

*Prepaid Expenses*

Prepaid expenses consist primarily of payments made for services to be received in future periods and are expensed as the services are consumed. As of March 31, 2026 and December 31, 2025, prepaid expenses totaled $12,945 and $25,445, respectively.

*Intangible Asset*

Intangible assets are recorded at cost and amortized over their estimated useful lives unless determined to have an indefinite useful life.

For definite-lived intangible assets, the Company evaluates impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If such indicators are present, the Company compares the expected undiscounted future cash flows attributable to the asset to its carrying amount. If the carrying amount exceeds the expected undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the asset's fair value.

Indefinite-lived intangible assets are not amortized but are evaluated for impairment at least annually, or more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired.

As of March 31, 2026, the Company's intangible assets consisted of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· AI
 App, net $180,000

· Formula-Pets
 $25,000

· Trademarks
 $1,500

Total intangible assets, net, were $206,500 as of March 31, 2026 and $216,500 as of December 31, 2025. The decrease during the quarter was attributable to $10,000 of amortization expense on the AI App intangible asset. No impairment was recorded during the three months ended March 31, 2026 or 2025.

As of March 31, 2025, the Company's intangible assets totaled $30,100, compared with $31,300 at December 31, 2024.

Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company's AI application is amortized over five years, and the Company's website was amortized over two years and was fully amortized as of December 31, 2025. Amortization expense was $10,000 for the three months ended March 31, 2026 and $1,200 for the three months ended March 31, 2025.

*Stock Compensation*

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation—Stock Compensation. Stock-based compensation expense is recognized based on the fair value of equity instruments issued.

The Company is authorized to issue 75,000,000 shares of common stock, par value $0.001 per share. As of March 31, 2026 and December 31, 2025, there were 43,690,580 and 42,690,580 shares of common stock issued and outstanding, respectively (see Note 5).

During the three months ended March 31, 2026, the Company issued 1,000,000 shares of common stock for cash proceeds of $50,000 and recorded $1,000 to common stock and $49,000 to additional paid-in capital.

No shares were issued for services during the three months ended March 31, 2026 or 2025.

*Impairment Of Long-Lived Assets*

The Company accounts for impairment of intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. Definite-lived intangible assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are not amortized but are tested for impairment at least annually, or more frequently if events or changes in circumstances indicate potential impairment.

As of March 31, 2026, the carrying value of the Formula-Pets intangible asset was $25,000. No impairment charge was recorded during the three months ended March 31, 2026 or 2025.

*Revenue Recognition* 

The Company accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customers. Under ASC 606, revenue is recognized when control of promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services.

The Company's revenue for the three months ended March 31, 2026 and 2025 was derived primarily from distribution rights, licenses, and affiliate commissions.

For each contract, the Company first determines whether an arrangement exists that creates enforceable rights and obligations. The Company then identifies the distinct performance obligations promised in the contract. The transaction price is determined based on the consideration the Company expects to receive under the terms of the arrangement, including fixed amounts and, when applicable, estimates of variable consideration to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. When a contract contains more than one performance obligation, the transaction price is allocated to each performance obligation based on its relative standalone selling price.

Revenue from distribution rights is recognized at the point in time or over the period in which the customer obtains control of the contractual rights, depending on the nature of the arrangement and the Company's performance obligations under the contract.

Revenue from licenses is recognized when the licensed intellectual property is made available to the customer or over the license term, depending on whether the license provides a right to use intellectual property as it exists at a point in time or a right to access intellectual property as it evolves over time.

Revenue from affiliate commissions is recognized at the time the underlying qualifying transaction occurs and the commission is earned, which is the point at which the Company's performance obligation is satisfied.

The Company evaluates each contract to determine whether it acts as principal or agent, as applicable, and records revenue on a gross or net basis consistent with that determination. Payment terms vary by contract but are generally due within 30 to 90 days. Amounts billed and collected in advance of satisfying the related performance obligations are recorded as deferred revenue. No deferred revenue was recorded as of March 31, 2026 or December 31, 2025.

*Fair Value of Financial Instruments* 

ASC 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. The carrying amounts of cash and cash equivalents, accounts receivable, loan payable, and accounts payable approximate fair value because of the short-term maturities of these instruments. The Company applies ASC 820, Fair Value Measurement, which establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels: Level 1, quoted prices in active markets for identical assets or liabilities; Level 2, observable inputs other than quoted prices included in Level 1; and Level 3, unobservable inputs reflecting the Company's own assumptions. As of March 31, 2026 and December 31, 2025, the Company had no financial instruments measured at fair value on a recurring basis.

*Income Taxes* 

In accordance with ASC 740 *Income Taxes*, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in Income in the period that includes the enactment date.

The Company has adopted the provisions set forth in ASC 740 to account for uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of the income tax law. The taxing authorities may challenge such positions, and the resolution of such matters could result in recognition of Income tax expense in the Company's financial statements. Management believes it has used reasonable judgments and conclusions in the preparation of its income tax returns. The Company uses the "more likely than not" criterion for recognizing the tax benefit of uncertain tax positions and to establish measurement criteria for income tax benefits. The Company' s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on its balance sheets as of December 31, 2025, and December 31, 2024.

The Company has incurred net operating losses and has established a full valuation allowance against its deferred tax assets. As a result, no income tax expense or benefit was recorded for the three months ended March 31, 2026 or 2025.

*Earnings Per Share of Common Stock*

Net loss per share is computed in accordance with ASC 260, *Earnings Per Share*. Basic net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per share gives effect to potentially dilutive securities, including warrants, using the treasury stock method. During the quarter ended March 31, 2026, the Company issued 1,000,000 warrants exercisable for cash. The warrants were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive.

*Recently Adopted Accounting Pronouncements*

Management does not believe that any recently issued, but not yet effective, accounting pronouncements would have a material effect on the accompanying interim financial statements.

**Note 3 - Commitments and Contingencies**

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with ASC 450, Contingencies. As of March 31, 2026 and December 31, 2025, the Company was not aware of any contingent liabilities or commitments that required accrual or disclosure in the accompanying unaudited financial statements.

**Note 4 - Segment Disclosure**

ASC 280, Segment Reporting, establishes standards for reporting information about operating segments. The Company manages its business on the basis of one reportable segment and derives revenues mainly from products, licensing rights, distribution rights, and affiliate commissions.

The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the chief operating decision maker ("CODM"). The Company's CODM is its chief executive officer, who reviews financial information and operating plans for purposes of making operating decisions, evaluating financial performance, and allocating resources.

The key measure of segment profit or loss that the CODM uses to allocate resources and assess performance is the Company's net loss.

Segment Disclosures for the Quarters Ended:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2025** |
| &nbsp;&nbsp;**Sales** |  |  |
| &nbsp;&nbsp; Revenues | $21800 | $12972 |
| &nbsp;&nbsp;**Net Sales** | 21800 | 12972 |
| &nbsp;&nbsp; Cost of Goods Sold |  |  |
| &nbsp;&nbsp;**Gross Profit** | 21800 | 12972 |
| &nbsp;&nbsp;**Sales, marketing and support** |  |  |
| &nbsp;&nbsp; Marketing costs | 64589 |  |
| &nbsp;&nbsp; Professional fees | 23796 |  |
| &nbsp;&nbsp; Amortization | 10000 | 1200 |
| &nbsp;&nbsp; Consulting | 43700 | 12650 |
| &nbsp;&nbsp; General and Administrative costs | 5056 | 234 |
| &nbsp;&nbsp;**Net Income (Loss) Before Taxes** | $(125341) | $(1112) |

---

**Note 5 – Stockholders' Equity**

The Company is authorized to issue 75,000,000 shares of common stock, par value $0.001 per share. As of March 31, 2026, there were 43,690,580 shares of common stock issued and outstanding. As of December 31, 2025, there were 42,690,580 shares issued and outstanding.

Set forth below is information regarding the issuance and sales of securities without registration through March 31, 2026. No such sales involved the use of an underwriter, no advertising or public solicitation was involved, the securities bear a restrictive legend, and no commissions were paid in connection with the sale of any securities.

Since January 1, 2025 through March 31, 2026, the Company issued an aggregate of 11,520,580 shares of common stock, consisting of 9,400,000 shares issued for services, 173,913 shares issued for an asset, and 1,946,667 shares issued for cash. The related amounts recorded were as follows: shares issued for services — common stock of $9,400 and additional paid-in capital of $754,795; shares issued for asset acquisition — common stock of $174 and additional paid-in capital of $295,393; and shares issued for cash — common stock of $1,947 and additional paid-in capital of $156,991. During the three months ended March 31, 2026, the Company issued 1,000,000 shares for cash proceeds of $50,000.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On June 8, 2025, the Company
 issued 1,500,000 shares of common stock to a non-affiliated entity for services.

· On June 9, 2025, the Company
 issued 1,000,000 shares of common stock to a non-affiliated individual for services.

· On July 5, 2025, the Company
 issued 500,000 shares of common stock to a non-affiliated individual for services.

· On July 8, 2025, the Company
 issued 1,000,000 shares of common stock to a non-affiliated entity for services.

· On July 29, 2025, the Company
 issued 66,667 shares of common stock to a non-affiliated individual for cash.

· On August 20, 2025, the
 Company issued 173,913 shares of common stock to a non-affiliated entity in exchange for an asset.

· On September 23, 2025,
 the Company issued 200,000 shares of common stock to a non-affiliated individual for services.

· On October 10, 2025, the
 Company issued 500,000 shares of common stock to a non-affiliated entity for services.

· On October 15, 2025, the
 Company issued an aggregate of 1,780,000 shares of common stock, consisting of 1,500,000 shares issued to a non-affiliated entity
 for services and 280,000 shares issued to a non-affiliated individual for cash.

· On November 1, 2025, the
 Company issued 1,400,000 shares of common stock to a non-affiliated individual for services.

· On November 3, 2025, the
 Company issued 1,000,000 shares of common stock to a non-affiliated individual for services.

· On November 12, 2025, the
 Company issued 1,000,000 shares of common stock to a non-affiliated individual for services.

· On November 28, 2025, the
 Company issued 400,000 shares of common stock to a non-affiliated individual for cash.

· On January 23, 2026, the
 Company issued 500,000 shares of common stock to a non-affiliated individual for cash.

· On January 28, 2026, the
 Company issued 500,000 shares of common stock to a non-affiliated individual for cash.

On February 5, 2022, the Company issued 230,000 shares of common stock to Andrew Read at $0.01 per share for $2,300. On December 28, 2023, the Company issued 22,000,000 shares of common stock to Andrew Read at $0.01 per share for services. The issuances were exempt from registration by reason of Section 4(a)(2) of the Securities Act as transactions not involving a public offering.

The Company issued 6,940,000 shares in a Regulation D, Rule 506 offering filed with the SEC on March 11, 2022, at an offering price of $0.01 per share, resulting in total proceeds of $69,400. None of the investors were affiliated with any of the Company's directors, officers, promoters, or beneficial owners of 10% or more of its securities.

As of March 31, 2026, the Company had 43,690,580 shares of common stock issued and outstanding.

**Warrants**

During 2025, the Company issued warrants to purchase an aggregate of 946,667 shares of common stock to the Beling Family Trust. During the three months ended March 31, 2026, the Company issued additional warrants to purchase an aggregate of 1,000,000 shares of common stock to the Beling Family Trust.

A summary of warrant activity for the three months ended March 31, 2026 is as follows:

---

| | | |
|:---|:---|:---|
| | **Warrants** | **Weighted Average Exercise Price** |
| Outstanding at December 31, 2025 | 946667 | $0.08 |
| Granted | 1000000 | $0.05 |
| Exercised |  | $— |
| Expired |  | $— |
| Outstanding at March 31, 2026 | 1946667 | $0.06 |
| Exercisable at March 31, 2026 | 1946667 | $0.06 |

---

As of March 31, 2026, 1,946,667 warrants were outstanding and exercisable, with a weighted average exercise price of $0.06 per share.

The following table summarizes warrants outstanding at March 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Grant Date** | **Shares Under Warrant** | **Exercise Price** | **Expiration Date** | **Exercise Terms** |
| July 29, 2025 | 66667 | $0.30 | July 29, 2028 | Cash exercise |
| September 8, 2025 | 200000 | $0.10 | September 8, 2028 | Cash exercise |
| October 15, 2025 | 280000 | $0.05 | October 15, 2028 | Cash exercise |
| November 28, 2025 | 400000 | $0.05 | November 28, 2028 | Cash exercise |
| January 23, 2026 | 500000 | $0.05 | January 23, 2029 | Cash exercise |
| January 28, 2026 | 500000 | $0.05 | January 28, 2029 | Cash exercise |
| Total / Weighted Average | **1946667** | $**0.06** |  |  |

---

**Weighted Average term remaining:**

*For the current period issuances:*

 

1,000,000 warrants issued during the quarter ended March 31, 2026 had a weighted-average remaining contractual term of approximately 2.83 years.

*For the total warrants outstanding at March 31, 2026:*

1,946,667 warrants outstanding had a weighted-average remaining contractual term of approximately 2.70 years.

We have never utilized an underwriter for an offering of our securities. Other than the securities mentioned above and the common stock issuances described below, we have not issued or sold any other securities.

During the three months ended March 31, 2026, the Company issued 1,000,000 shares of common stock to the Beling Family Trust for aggregate proceeds of $50,000 pursuant to subscription agreements.

**Note 6 *-* Going Concern**

The Company has incurred recurring losses and, as of March 31, 2026 and December 31, 2025, had accumulated deficits of $1,308,408 and $1,183,067, respectively. In addition, the Company used $76,041 of cash in operating activities during the three months ended March 31, 2026. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

The Company's ability to continue as a going concern is dependent upon its ability to obtain additional financing and achieve profitable operations. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**Note 7 *-* Income Taxes**

The Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of events that have been recognized in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

The components of the Company's reconciliation of income taxes computed at the statutory rate of 21% to the income tax amount recorded for the three months ended March 31, 2026 and 2025 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Schedule of reconciliation of income taxes |  |  |  |  |
|  | **March 31, 2026** | **Rate** | **March 31, 2025** | **Rate** |
| &nbsp;&nbsp;Net Loss Before Taxes | (125341) | 100% | (1112) | 100% |
| &nbsp;&nbsp;Tax benefit at federal statutory rate | (26322) | (21)% | (234) | (21)% |
| &nbsp;&nbsp;State income taxes, net of federal benefit |  | 0.0% |  | 0.0% |
| &nbsp;&nbsp;Change in valuation allowance | 26322 | 21% | 234 | 21% |
| &nbsp;&nbsp;Provision from Income Taxes |  | 0.0% |  | 0.0% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **Rate** | **March 31, 2025** | **Rate** |
| &nbsp;&nbsp;Deferred Tax Asset | 26322 | 21% | 234 | 21% |
| &nbsp;&nbsp;Less Valuation Allowance | (26322) | (21)% | (234) | (21)% |
| &nbsp;&nbsp;Net Deferred Tax Asset |  | 0.0% |  | 0.0% |

---

Because of uncertainties surrounding the Company's ability to generate future taxable income to realize deferred tax assets, a full valuation allowance has been established. Accordingly, no income tax provision or benefit was recorded for the three months ended March 31, 2026 or 2025.

**Note 8 - Subsequent Events**

In accordance with ASC 855, *Subsequent Events*, the Company has evaluated subsequent events through the date these financial statements were issued. Management has determined that there were no material subsequent events requiring recognition or disclosure in the financial statements for the quarter ended March 31, 2026.

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes to those statements included elsewhere in this prospectus. In addition to historical financial information, the following discussion and analysis contain forward-looking statements involving risks, uncertainties, and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements due to many factors, including, but not limited to, those discussed under the section titled "Risk Factors" and elsewhere in this prospectus. See the section titled "Special Note Regarding Forward-Looking Statements" elsewhere in this prospectus.*

**Overview**

Tradewinds Universal ("Tradewinds" or the "Company") is a holding company focused on acquiring and developing businesses with long-term value, resilience, and growth potential. Our initial operations focused on the development and distribution of high-nutrition foods and beverages, including edible insect protein-based bars marketed under the Universal Proteins (UP) brand. In 2022, we also acquired a canine pain relief formula for development into pet treats.

In August 2025, we signed a Letter of Intent with Peppermint Hippo(TM) to create a dedicated nightlife and hospitality division. The LOI includes the acquisition of Peppermint Hippo Toledo as the initial property, followed by a phased rollout of several clubs nationwide, including 8 Peppermint Hippo locations and other affiliated brands owned or operated by Peppermint Hippo. This move represents a major strategic expansion into a new industry sector.

We successfully completed the development, manufacturing, and initial distribution of two protein bar SKUs (Chocolate Almond and Peanut Butter Fruit) in 2023 through our partnership with YouBar, Inc. In 2024, we entered into a purchase agreement with a distributor for 1,040 cases of UP bars, all of which were sold by September 30, 2024. We continue to market our bars online and to retail outlets, but larger-scale distribution agreements remain uncertain. Development of additional SKUs is ongoing.

Looking ahead, we intend to keep expanding our UP product line, move forward with commercializing our canine pain relief formula, explore licensing and distribution opportunities, and evaluate opportunities in the nightlife and hospitality markets. We expect operating expenses to remain elevated as we develop new product lines, pursue strategic opportunities, and continue as a public company. Net losses are likely to vary depending on the timing of marketing efforts, research and development activities, professional fees, and potential acquisitions. We are working on securing funding through additional equity or debt financing to support our growth plans.

**Comparison of the Quarters Ended March 31, 2026 and March 31, 2025**

**Revenue**

For the quarter ended March 31, 2026, the Company generated revenue of $21,800, compared to revenue of $12,972 for the quarter ended March 31, 2025. Revenue increased by $8,828, or approximately 68%, primarily due to increased licensing, distribution, and related business activity during the 2026 period.

**Gross Profit**

Gross profit for the quarter ended March 31, 2026 was $21,800, compared to gross profit of $12,972 for the quarter ended March 31, 2025. The Company did not report cost of goods sold for either period presented, and therefore gross profit equaled revenue in both periods.

**Operating Expenses**

Total operating expenses for the quarter ended March 31, 2026 were $147,141, compared to $14,084 for the quarter ended March 31, 2025, an increase of $133,057. Operating expenses for the 2026 period included marketing expense of $64,178, advertising expense of $411, professional fees of $23,796, consulting expense of $43,700, amortization expense of $10,000, and general and administrative expense of $5,056. Operating expenses for the 2025 period consisted primarily of consulting expense of $12,650, amortization expense of $1,200, and general and administrative expense of $234.

The increase in operating expenses was primarily attributable to higher marketing activity, professional fees, consulting expenses, amortization, and general and administrative costs incurred in connection with business development activities, strategic initiatives, and the Company's public-company obligations.

**Net Loss**

For the quarter ended March 31, 2026, the Company recorded a net loss of $125,341, compared to a net loss of $1,112 for the quarter ended March 31, 2025. The increase in net loss was primarily driven by the increase in operating expenses, partially offset by the increase in revenue and gross profit. Basic and diluted net loss per share was $0.01 for the quarter ended March 31, 2026, compared to $0.00 for the quarter ended March 31, 2025. Weighted average shares outstanding used in the calculation of basic and diluted net loss per share were 43,418,358 for the quarter ended March 31, 2026 and 32,170,000 for the quarter ended March 31, 2025.

**Liquidity and Capital Resources**

As of March 31, 2026, the Company had total assets of $283,992, compared to total assets of $307,333 as of December 31, 2025. Current assets at March 31, 2026 were $77,492, consisting of cash and cash equivalents of $15,597, prepaid expenses of $12,945, and accounts receivable of $48,950. Other assets, net, were $206,500 at March 31, 2026, consisting primarily of the AI app intangible asset, net of amortization, of $180,000, the Formula-Pets intangible asset of $25,000, and trademarks of $1,500.

As of March 31, 2026, the Company had total liabilities of $52,000, consisting of a loan payable of $25,000 and accounts payable of $27,000. The Company had no liabilities reported at December 31, 2025. Stockholders' equity totaled $231,992 at March 31, 2026, compared to $307,333 at December 31, 2025. The decrease in stockholders' equity during the quarter was primarily attributable to the net loss of $125,341, partially offset by the issuance of common stock for cash.

At March 31, 2026, the Company had 43,690,580 shares of common stock issued and outstanding, compared to 42,690,580 shares issued and outstanding at December 31, 2025. Additional paid-in capital was $1,496,709 at March 31, 2026, compared to $1,447,709 at December 31, 2025. The accumulated deficit increased to $1,308,408 at March 31, 2026 from $1,183,067 at December 31, 2025.

The Company continues to have limited cash resources. At March 31, 2026, cash and cash equivalents were $15,597. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The Company will require additional capital to fund ongoing operations and future growth initiatives. Management intends to pursue additional equity financing, debt financing, licensing revenue growth, and strategic partnerships; however, there can be no assurance that such financing or revenue will be available on acceptable terms, or at all.

**Cash Flows**

**Operating Activities**

Net cash used in operating activities was $76,041 for the quarter ended March 31, 2026, compared to net cash provided by operating activities of $88 for the quarter ended March 31, 2025. The cash used in operating activities during the 2026 period was primarily attributable to the net loss of $125,341, partially offset by non-cash amortization of $10,000, a decrease in prepaid expenses of $12,500, an increase in accounts payable of $27,000, and a $200 increase in accounts receivable.

**Investing Activities**

The Company had no cash provided by or used in investing activities for the quarters ended March 31, 2026 and March 31, 2025.

**Financing Activities**

Net cash provided by financing activities was $75,000 for the quarter ended March 31, 2026, consisting of $25,000 from a loan and $50,000 from the issuance of common stock. The Company had no cash provided by or used in financing activities for the quarter ended March 31, 2025.

As a result of the foregoing, cash and cash equivalents decreased by $1,041 during the quarter ended March 31, 2026, from $16,638 at December 31, 2025 to $15,597 at March 31, 2026. For the quarter ended March 31, 2025, cash and cash equivalents increased by $88, from $210 at December 31, 2024 to $298 at March 31, 2025.

**Off Balance Sheet Items**

The Company does not have any off-balance sheet arrangements, special purpose entities, or other relationships that would have a material effect on its financial condition or results of operations.

**Significant Accounting Policies and Estimates**

The Company's financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Significant estimates include the valuation and impairment of intangible assets, stock-based compensation, and the recognition of revenue from licensing and distribution agreements. Actual results may differ from those estimates.

**Outlook**

Management expects operating expenses to remain elevated as the Company continues to develop licensing opportunities, pursue strategic acquisitions, evaluate opportunities in the nightlife and hospitality sector, and meet its obligations as a public company. While management believes that the Company's strategic shift toward licensing, distribution, and selected acquisitions may provide improved margins and scalability, the Company expects to continue incurring net losses in the near term. The Company's ability to achieve profitability will depend on its ability to generate sustainable revenues, control operating costs, and secure additional financing as needed.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Not applicable.

**ITEM 4. CONTROLS AND PROCEDURES**

 ****

*Evaluation of Disclosure Controls and Procedures.* Our principal executive officer and principal financial officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q, have concluded that, based on such evaluation, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

*Changes in Internal Control over Financial Reporting.* There were no changes in our internal control over financial reporting, identified in connection with the evaluation of such internal control that occurred during the quarter ended March 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

*Management's Quarterly Report on Internal Control over Financial Reporting.* Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, as a process designed by, or under the supervision of, our principal executive officer and principal financial officer and effected by our board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

● pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

● provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of management and our directors; and

● provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Based on our evaluation of internal controls, our management concluded that there is a lack of segregation of duties identified. As a result our internal controls over financial reporting were not effective as of March 31, 2026.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

**PART II - OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

We know of no material, existing, or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

**ITEM 1A. RISK FACTORS**

As a smaller reporting company, we are not required to provide the information required by this item.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

The Company is authorized to issue 75,000,000 shares of common stock, par value $0.001 per share. As of March 31, 2026, there were 43,690,580 shares of common stock issued and outstanding.

Set forth below is information regarding the issuance and sales of securities without registration since inception. No such sales involved the use of an underwriter; no advertising or public solicitation was involved; the securities bear a restrictive legend; and no commissions were paid in connection with the sale of any securities.

As of March 31, 2026, we have issued an aggregate of 11,520,580 shares: 9,400,000 shares to 10 people for services, 173,913 shares for an asset, and an aggregate of 1,946,667 shares for cash. The related amounts recorded were as follows: shares issued for services — common stock of $9,400 and additional paid-in capital of $754,795; shares issued for cash — common stock of $1,947 and additional paid-in capital of $156,991; and shares issued for asset acquisition — common stock of $174 and additional paid-in capital of $295,393. The issuances were exempt from registration under Section 4(a)(2) of the Securities Act as issuances not involving a public offering.

Such issuances were made to a limited number of non-affiliated individuals and non-affiliated entities as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On June 8, 2025, the Company
 issued 1,500,000 shares of common stock to a non-affiliated entity for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On June 9, 2025, the Company
 issued 1,000,000 shares of common stock to a non-affiliated individual for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On July 5, 2025, the Company
 issued 500,000 shares of common stock to a non-affiliated individual for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On July 8, 2025, the Company
 issued 1,000,000 shares of common stock to a non-affiliated entity for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On July 29, 2025, the Company
 issued 66,667 shares of common stock to a non-affiliated individual for cash.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On August 20, 2025, the
 Company issued 173,913 shares of common stock to a non-affiliated entity in exchange for an asset.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On September 23, 2025,
 the Company issued 200,000 shares of common stock to a non-affiliated individual for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On October 10, 2025, the
 Company issued 500,000 shares of common stock to a non-affiliated entity for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On October 15, 2025, the
 Company issued an aggregate of 1,780,000 shares of common stock, consisting of 1,500,000 shares issued to a non-affiliated entity
 for services and 280,000 shares issued to a non-affiliated individual for cash.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On November 1, 2025, the
 Company issued 1,400,000 shares of common stock to a non-affiliated individual for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On November 3, 2025, the
 Company issued 1,000,000 shares of common stock to a non-affiliated individual for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On November 12, 2025, the
 Company issued 1,000,000 shares of common stock to a non-affiliated individual for services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On November 28, 2025, the
 Company issued 400,000 shares of common stock to a non-affiliated individual for cash.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On January 23, 2026 the
 Company issued 500,000 shares of common stock to a non-affiliated individual for cash.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· On January 28, 2026 the
 Company issued 500,000 shares of common stock to a non-affiliated individual for cash.

**Warrants**

During 2025, the Company issued warrants to purchase an aggregate of 946,667 shares of common stock to the Beling Family Trust. During the three months ended March 31, 2026, the Company issued additional warrants to purchase an aggregate of 1,000,000 shares of common stock to the Beling Family Trust.

A summary of warrant activity for the three months ended March 31, 2026 is as follows:

---

| | | |
|:---|:---|:---|
| | **Warrants** | **Weighted Average Exercise Price** |
| Outstanding at December 31, 2025 | 946667 | $0.08 |
| Granted | 1000000 | $0.05 |
| Exercised |  | $— |
| Expired |  | $— |
| Outstanding at March 31, 2026 | 1946667 | $0.06 |
| Exercisable at March 31, 2026 | 1946667 | $0.06 |

---

As of March 31, 2026, 1,946,667 warrants were outstanding and exercisable, with a weighted average exercise price of $0.06 per share.

The following table summarizes warrants outstanding at March 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Grant Date** | **Shares Under Warrant** | **Exercise Price** | **Expiration Date** | **Exercise Terms** |
| July 29, 2025 | 66667 | $0.30 | July 29, 2028 | Cash exercise |
| September 8, 2025 | 200000 | $0.10 | September 8, 2028 | Cash exercise |
| October 15, 2025 | 280000 | $0.05 | October 15, 2028 | Cash exercise |
| November 28, 2025 | 400000 | $0.05 | November 28, 2028 | Cash exercise |
| January 23, 2026 | 500000 | $0.05 | January 23, 2029 | Cash exercise |
| January 28, 2026 | 500000 | $0.05 | January 28, 2029 | Cash exercise |
| Total / Weighted Average | **1946667** | $**0.06** |  |  |

---

We have never utilized an underwriter for an offering of our securities. Other than the securities mentioned above and the common stock issuances described below, we have not issued or sold any other securities.

During the three months ended March 31, 2026, the Company issued 1,000,000 shares of common stock to the Beling Family Trust for aggregate proceeds of $50,000 pursuant to subscription agreements.

On February 5, 2022, the Company issued 230,000 shares of common stock to Andrew Read at $.01 for $2,300. On December 28, 2023, the Company issued 22,000,000 shares of common stock to Andrew Read at $.01 for services. The issuances were exempt from registration by reason of Section (4)(a)(2) of the Securities act as issuances not involving a public offering.

The company issued 6,940,000 shares in a Regulation D, Rule 506 offering which was filed with the SEC on March 11, 2022, done in compliance with Section (4)(a)(2) of the 1933 Act, at an offering price of $0.01 per share, resulting in total proceeds of $69,400 and a sale of 6,940,000 shares in aggregate. None of the investors are affiliated with any of our directors, officers or promoters or any beneficial owner of 10% or more of our securities

As of March 31, 2026, the Company had 43,690,580 shares of common stock issued and outstanding.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5. OTHER INFORMATION**

None.

**ITEM 6. EXHIBITS**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
| <br>**No.** | <br>**Exhibit Description** | **Form** | **Date Filed** | **Number** | **Filed or**<br> **Furnished**<br>**Herewith** |
| 31.1 | [Certification of the Chief Executive Officer, as the principal executive officer and the principal financial officer, under 18 U.S.C. Section 1350, as adopted in accordance with section 302 of the Sarbanes-Oxley Act of 2002.](ex31x1.htm) |  |  |  | Filed |
| 32.1 | [Certification of the Chief Executive Officer, as the principal executive officer and the principal financial officer, under 18 U.S.C. Section 1350, as adopted in accordance with Section 906 of the Sarbanes-Oxley Act of 2002.](ex32x1.htm) |  |  |  | Furnished |
| 101. | Interactive Data files |  |  |  | Filed |

---

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Dated: May 14, 2026 | **TRADEWINDS UNIVERSAL** | **TRADEWINDS UNIVERSAL** |
|  | By: | /s/ Andrew Read |
|  |  | Andrew Read, |
|  |  | Chief Executive Officer |
|  |  | /s/ Andrew Read |
|  |  | Andrew Read, |
|  |  | Chief Financial Officer |

---

In accordance with the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates stated.

---

| | | |
|:---|:---|:---|
| SIGNATURE | TITLE | DATE |
| <u>/s/ Andrew Read</u><br> Andrew Read | President/Chief Executive Officer and Director(principal executive officer) | May 14, 2026 |
| <u>/s/ Andrew Read</u> <br> Andrew Read | Chief Financial Officer and Director (principal accounting officer) | May 14, 2026 |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION**

I, Andrew Read, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Tradewinds Universal (the "Company") for the quarter ended March 31, 2026;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: May 14, 2026 |  |  |
|  | By: | ***/s/ Andrew Read*** |
|  | Title: | Chief Executive Officer and Director<br> (Principal Executive Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Tradewinds Universal (the "Company") on Form 10-Q for the period ending March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 14, 2026 |  |  |
|  | By: | ***/s/ Andrew Read*** |
|  | Title: | Chief Executive Officer and Director<br> (Principal Executive Officer) |

---